Italia - italiensk - Ministero della Salute

phenox gmbh - cateteri per embolectomia

Den europeiske union - italiensk - EMA (European Medicines Agency)

astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - malattia polmonare, ostruttiva cronica - formoterolo e glycopyrronium bromuro - bevespi aerosphere è indicato come un broncodilatatore di mantenimento di trattamento per alleviare i sintomi in pazienti adulti con malattia polmonare ostruttiva cronica (bpco).

Den europeiske union - italiensk - EMA (European Medicines Agency)

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - malattia polmonare, ostruttiva cronica - farmaci per le malattie respiratorie ostruttive, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Den europeiske union - italiensk - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - malattia polmonare, ostruttiva cronica - farmaci per le malattie respiratorie ostruttive, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Den europeiske union - italiensk - EMA (European Medicines Agency)

laboratorios lesvi s.l. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 36 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 54 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 27 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika

Sveits - italiensk - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, zucchero sfere corrisp. sintetico 10.9 mg, hypromellosum, talco, acido hydrochloridum, ethylcellulosum, hydroxypropylcellulosum, triethylis citras, hypromellosi acetas succinas, carmellosum natricum corrisp. sodio 3.87 mg, cellulosum microcristallinum, magnesio stearas, silice colloidalis anhydrica, Überzug: poli(alcole vinylicus), talco, macrogolum 3350, e 171, e 172 (giallo), acido hydrochloridum, per compresso haze. - centrale efficiente ad azione prolungata - synthetika